Postpartum Depressive Disorder

2

Review clinical trials related to Postpartum Depressive Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

This is a study evaluating the efficacy, and safety of KH607 in 72 participants diagnosed with Postpartum Depressive Disorder.

Participants needed: 72
Trial details
Phase: Phase 2Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.Updated: Jul 31, 2025
Eligibility criteria

Age: 18 to 45 years old (inclusive), female. [+5]

Participant is currently at significant risk of suicide, or has attempted suicid... [+6]

Status: Recruiting

Powerly - Science-based Digital Intervention Preventing Postpartum Depression and Anxiety

The goal of this clinical trial is to determine if the Powerly app can help prevent postpartum depression and anxiety in healthy pregnant women. The main questions it aims to answer are: * Does the Powerly app reduce postpartum depression and anxiety? * Does it improve emotion regulation and maternal bonding with a child? Researchers will compare two groups: one using the Powerly app and the other receiving care as usual (CAU) to see if the app leads to better mental health outcomes. Participants will: * Use the Powerly app for four weeks (if in the intervention group). * Complete mental health assessments before the study, after four weeks, and six weeks postpartum.

Participants needed: 140
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Marta MarciniakUpdated: May 20, 2025Locations: 1
Eligibility criteria

being between 24 and 32 weeks pregnant, [+2]

high-risk pregnancies, [+3]